New Cousteau-Linked...
Health Care: Drugs
Compugen Ltd. (CGEN: NASDAQ)
$3.41 -0.12 | -3.40%
06/01/12 - 04:00 PM ET
TheStreet Ratings Grade for CGEN
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Stong Buy | 0 | 0 | 0 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0.00 | 0.00 | 0.00 | 1.00 |
Portfolios with CGEN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Contributor5 Bargain Biotech Stocks
- Userdesignbydiana Portfolio 1
- Userraveha1 Portfolio 1
- ContributorBiotech Short Squeezes
- UserSUPRATRADE-QUANTUM STARDUST 8
- UserHumelor Portfolio 1
Latest CGEN Headlines from TheStreet
- 7 Stocks Under $10 Soaring Higher 05.24.12 | 12:05 pm
- 5 Bargain Biotech Stocks 01.13.11 | 05:01 pm
- Maguire Properties, Compugen: Midday Volume Plays 05.11.10 | 11:05 am
- eOn Communications, Compugen: Early Volume Plays 03.16.10 | 09:03 am
- Pluristem Therapeutics, Compugen: Early Volume Plays 03.02.10 | 09:03 am
- Array BioPharma, Sterling Financial: Early Volume Plays 02.02.10 | 09:02 am
- Biotech's Movers & Shakers 2009: BioBuzz 01.04.10 | 09:01 am
- Compugen, Flotek: Early Volume Plays 01.04.10 | 07:01 am
- China BAK, Compugen: Early Volume Plays 12.30.09 | 08:12 am
- Compugen, Sinovac: Early Volume Plays 12.28.09 | 08:12 am
Press Releases for CGEN
- Dr. Mary Haak-Frendscho, Chairperson Of Compugen’s US Subsidiary, To Give Keynote Address At China Pharmaceutical R&D Summit - Business Wire 04.23.12 | 07:04 am
- Compugen First Quarter 2012 Conference Call Scheduled For Tuesday, May 1, 2012 At 10:00 AM EST - Business Wire 04.23.12 | 07:04 am
- Compugen Presents Prediction Based Discovery Strategy At “Targets And Strategies For Drug Discovery” Conference - Business Wire 02.27.12 | 07:02 am
- Compugen Cancer Target Results Demonstrate Significant Potential For Cancer Immunotherapy - Business Wire 02.02.12 | 06:02 am
- Compugen To Broaden And Accelerate Monoclonal Antibody Program For Oncology And Immunology - Business Wire 12.20.11 | 10:12 am
- BioLineRx To Develop And Commercialize Novel Peptide Drug Candidates Discovered By Compugen - Business Wire 12.13.11 | 06:12 am
- Compugen Presents Predictive Drug Target Discovery Platform At European Antibody Conference - Business Wire 11.30.11 | 07:11 am
- Www.discoverx.com - Business Wire 11.29.11 | 07:11 am
- Compugen Reports Third Quarter 2011 Financial Results - Business Wire 11.08.11 | 07:11 am
- Compugen's CGEN-15001 Pre-Clinical Data Presented At International Conference On Immune Tolerance - Business Wire 10.25.11 | 07:10 am
Partner Headlines for CGEN
- Life Sciences Companies Raise Record Amounts of Capital - Seeking Alpha 12.31.10 | 04:12 pm
- Compugen: On the Road to Breakthroughs - Seeking Alpha 05.12.10 | 03:05 am
